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Objectives.Lis study examines the short- and long-termQOL beneTts of amusic therapy intervention for patients recovering from
hematopoietic stem cell transplantation (HSCT).Methods. Ninety allogeneic HSCT patients, a[er transplant, were randomized to
receive ISO-principle (i.e., mood matching) based music therapy (MT; ! = 29), unstructured music (UM; ! = 30), or usual care
(UC; ! = 31) for four weeks. Le ISO principle posits that patients may shi[ their mood from one state to another by listening
to music that is “equal to” the individual’s initial mood state and subsequently listening to music selections that gradually shi[ in
tempo and mood to match the patient’s desired disposition. Participants in MT and UM groups developed two audio CDs to help
them feel more relaxed and energized and were instructed to use the CDs to improve their mood as needed. Short-term eKects
on mood and long-term eKects on QOL were examined. Results. MT and UM participants reported improved mood immediately
a[er listening to CDs; the within-group eKect was greater for UM participants compared toMT participants. Participant group was
not associated with long-term QOL outcomes. Conclusions. Music listening improves mood acutely but was not associated with
long-term beneTts in this study.
1. Introduction
Allogeneic hematopoietic stem cell transplantation (HSCT) is
used to treat a variety of malignant diseases.Le procedure is
regarded as one of the most dibcult oncologic interventions
due to the common and intense side eKects of high dose
chemotherapy and gra[-versus-host disease such as organ
toxicity (e.g., pulmonary and cardiac), osteoporosis, infec-
tion, cataracts, and infertility [1–8]. Not surprisingly, HSCT
has been associated with diminished quality of life (QOL),
especially in the Trst 100 days a[er transplant period [2–5].
Le period of lowest white blood cell count, nadir, which
typically occurs within the Trst 30 days a[er transplant, has
been identiTed as the time when patients report the greatest
symptom distress [9] although patients may report symptom
distress for as long as 3–5 years a[er transplant [10]. Le
acute complications of HSCTmay prevent patients from par-
ticipating in common symptom management interventions
[6]. Lus, Tnding eKective methods to alleviate distress and
improve coping skills and emotional well-beingmay improve
post-transplant QOL as well as reduce symptomdistress [2, 7,
8, 11].
Music therapy, which requiresminimal physical exertion,
may be an ideal intervention for helping HSCT patients
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manage their emotions and control stress. For the purpose of
our study, it is important to draw a distinction between the
passive and active use of music as an intervention. Passive
music listening o[en involves listening to music without a
music therapist, while active music therapy interventions
involve being engaged with a music therapist inluencing the
listening experience towards a therapeutic, and sometimes
insight-oriented, objective [12]. Music therapy has, with
varied success, been used to alleviate a broad range of cancer-
related symptoms, such as sleep dibculties, pain, anxiety,
depression, fatigue, and nausea, and to increase coping skills
and spiritual well-being [13–17]. A recent systematic review
of 30 trials examining the eKects of music interventions
for adult cancer patients found that music interventions
(both passive and active) were consistently associated with
improvements in anxiety, mood, and pain and less consis-
tently associated with improvements in fatigue and physical
functioning [18]. To date, only two studies examined the
eKect of a music intervention for adult HSCT patients and
suggest that music therapy may lower anxiety, depression,
and mood disturbance [19], as well as increase psychological
well-being and physical comfort [20]. Lese interventions
were individualized, involving both passive music listening
and active music creation, making it dibcult to determine
the mechanisms by which these music interventions led
to beneTcial eKects. Studies examining manualized music
therapy interventions would enable mechanisms of action
to be identiTed and would allow for better replication and
dissemination.
Le ISO principle is a music therapy strategy that lends
itself to a standardized treatment but has yet to be tested
in a controlled trial. Lis principle was Trst put forth by
psychiatrist Dr. Ira Altshuler in 1945 as a method of assisting
psychiatric patients in shi[ing their mood from depressed
to energized or from anxious to relaxed [21, 22]. Le “ISO”
(Greek for “equal”) principle involves beginning a music
therapy session by listening to music that is “equal to” the
individual’s initial mood state and subsequently listening to
music selections that gradually shi[ in tempo and mood to
match the patient’s desired disposition. For example, a patient
feeling depressed may begin by listening to music with slow
tempo that matches their mood. Lroughout the session,
the patient would listen to music selections that gradually
increase in tempo and become closer to their desired mood
(i.e., energized/joyful). A music therapy intervention based
on the ISO principle may be ideal for populations that would
beneTt from a mood management technique requiring little
physical exertion that can be used in a variety of settings (e.g.,
hospital or home).
Le primary aim of the present study was to assess short-
term (immediately a[er music listening) eKects of the ISO-
principlemusic therapy intervention. SpeciTcally, we hypoth-
esized that HSCT patients in the ISO-principle-based music
therapy group (MT) would report greater improvements in
mood immediately a[er listening to their music playlists
compared to individuals in the unstructured music listening
group (UM). Le secondary aim was to assess the long-term
(1 week and 1 month a[er intervention) eKects of the ISO-
principlemusic therapy intervention with the hypothesis that
theMTgroupwould, in turn, have better outcomes compared
to the UC group 1 week and 1 month a[er the intervention.
2. Methods
2.1. Patients. Ninety patients, age 18 or older, who had
undergone allogeneicHSCT and signed a consent less than 70
days earlier atMDAnderson Cancer Center between January
2004 andMay 2005were recruited for the study. For inclusion
in the study, patients needed to be ready to transition from
inpatient to outpatient status, or already an outpatient but
yet still and within the Trst 100 days of transplant. Patients
who had a known psychotic disorder were excluded from the
study. Each patient provided written informed consent, and
the studywas approved by the SurveillanceCommittee for the
Protection of Human Subjects.
2.2. Intervention. Patients were randomly assigned to one of
three groups: (1) ISO-principle music therapy (MT) group,
(2) unstructured music (UM) group, and (3) usual care
(UC) control group. Patients in the MT group met with
a music therapist (one board certiTed music therapist) for
four 50-minute sessions. In the Trst session participants were
introduced to the ISO principle and worked in collaboration
with the music therapist to select 15 tracks from a large
database that transitioned in tempo from allegro (120–168
beats per minute (BPM)) to largo (40–60 BMP) and in
mood from anxious/tense to relaxed. In the second session,
participants chose 15 tracks that transitioned in tempo from
largo (40–60 BMP) to allegro (120–168 BMP) and in mood
from sad/depressed to energized/joyful. Using these tracks,
the music therapist created two 30-minute CDs: the Trst was
designed to transition the patient from an anxious/tense state
to a relaxed state and the second was designed to transition
the patient from a sad/depressed state to an energized state.
In session 3 participants reviewed the two CDs andmade any
necessary changes, and in session 4 participants chose one of
their CDs and listened to it in its entirety.
Patients in the UM group met with a licensed mental
health therapist (one therapist) for four 50-minute sessions.
During session 1 they discussed the use of music to modify
mood, listened to diKerent music tracks, and selected 15
music tracks from the same database as the MT group that
made them feel relaxed. In session 2, patients selected 15
music tracks that made them feel energized. Le tracks were
organized into two 30-minute CDs (one including relaxing
songs and the second including energizing songs) based on
personal preference with little input from the therapist. In
session 3 participants reviewed the two CDs and made any
necessary changes, and in session 4 participants chose one of
their CDs and listened to it in its entirety.
Le diKerence in the MT and UM groups was only that
the tempo of the music as measured by BPM was modulated
from fast to slow (relaxing CD) or slow to fast (energizing
CD) in the MT group, while the BPM was not taken into
consideration in theUMgroup’s CDs. Patients in both groups
were instructed to listen to their CDs tomodify theirmood as
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needed and were asked to record their mood before and a[er
listening to their CDs in a listening log.
Patients in theUCgroup had nomusical intervention, did
not meet with a therapist, and received care as usual.
2.3. Procedures. At baseline, patients completed a 30-minute
battery of questionnaires and patients’ blood samples were
drawn for future assay (to be reported in a subsequent
manuscript). Le patients were then randomly assigned to
one of the three groups. MT and UM participants completed
assessments of mood before and a[er their Tnal music ther-
apy session. Our rationale for analyzing pre- and postsession
data is based on the idea that, if proven eKective, patients in
acute situations could utilize music therapy interventions for
situational relief of symptoms linked to medical procedures
[23]. All patients completed the mood and QOL measures
at the 1-week and 1-month follow-up. All follow-up assess-
ments were conducted within 100 days of HSCT. Patients’
demographic and clinical data were extracted from medical
records.
2.4. Measures. Changes in mood were assessed using the
short form of the ProTle of Mood States (POMS-SF) [24].
Le POMS-SF, which is commonly used in cancer research, is
a 37-item mood adjective checklist containing six subscales:
tension-anxiety, depression-dejection, anger-hostility, vigor,
fatigue, and confusion-bewilderment. To reduce the number
of analyses, the total mood disturbance score is reported with
high scores representing worse mood disturbance.
Health-related QOL was assessed using the Functional
Assessment of Cancer Lerapy-General (FACT-G) and the
Bone Marrow Transplant (FACT-BMT) subscale. Le FACT-
G yields an overall QOL score and assesses four subscales:
physical well-being, social/familywell-being, emotional well-
being, and functional well-being [25]. Le BMT subscale is
designed to assessQOL issues particularly relevant to patients
who have undergone a HSCT. Le FACT-G total score and
BMT score are reported with higher scores representing
better QOL and fewer symptoms.
Cancer-related symptoms were assessed using the MD
Anderson Symptom Inventory (MDASI) which evaluates 13
symptoms that are common across all cancer diagnoses and
treatments and also evaluates 6 functional areas in which
the symptoms may have interfered [26]. Patients rate the
intensity of each symptom and amount of interference they
have experienced on a scale from 0 to 10. An average score
was calculated creating a possible range of 0–10.
Participants were asked to complete a short music-
listening log each time they used their CDs for 1 month
a[er the intervention. Participants rated their level of relax-
ation/tension on a scale from 1 (extremely relaxed) to 10
(extremely tense) and their level of happiness/sadness on a
scale from 1 (extremely happy) to 10 (extremely sad) before
and a[er listening to their CDs.Ley also recordedwhich CD
they listened to (relaxing or energizing) and the number of
minutes that they listened.
2.5. Statistical Analysis. We used chi-square test and analysis
of variance (ANOVA) to examine possible group diKerences
in baseline demographic, medical, and self-report psychoso-
cial variables. We used ANOVA to determine if MT and
UM participants diKered in the frequency and duration that
they reported listening to their CDs. Using ANOVA, we
examined whether demographic or medical variables were
associated with self-report psychosocial outcome variables to
determine relevant covariates. Group comparisons of the self-
report psychosocial measures were performed by regressing
the assessments for eachmeasure on time, group assignment,
the group by time interaction, and the respective psychosocial
baseline measure using general linear mixed model regres-
sion analyses (LMM). Demographic and medical variables
found to have an association with the outcome measure were
included as covariates in these analyses. Le intercept was
treated as random, and the group eKect was treated as a
classiTcation variable using class statement in PROCMIXED
procedure. Le analyses of short-term outcomes based on
speciTc CDs with separate analyses, using LMM, included
only the MT and UM groups, with the UM group as the
reference group. In the analyses of long-term outcomes, the
UC group was the reference group. We treated time as a
classiTed variable using class statement and the last time
point in each model was the reference time point. As an
exploratory analysis, we also used LLM to examine changes
in psychosocial outcome measures over time (from baseline
to 1 month a[er intervention). We examined if there was an
association between the use of the CDs a[er the training
sessions and outcomes at 1 week and 1 month. Le SAS
statistical so[ware program (version 9.2; SAS, Cary, NC,
USA) was used to perform all analyses. Using G∗Power [27],
it was determined that a sample size of 21 patients for each
treatment group would enable us to detect a treatment eKect
equal to 0.50 standard deviations with 95% conTdence with
80% power. Anticipating attrition of 15% during the study, a
total of 90 participants were recruited.
3. Results
3.1. Patient Characteristics. Ninety individuals completed
baseline data (MT = 29, UM = 30, and UC = 31). Fi[y-
two percent of the participants were women, 66% married,
and 66% of Caucasian ethnicity, with a mean age of 44.3
years. A variety of cancer diagnoses were represented, with
the most common being leukemia (71%). Most patients
received transplant cells from matched related donors (57%)
and most donor cells were from peripheral blood (59%).
Forty-two percent of patients experienced gra[-versus-host
disease (GVHD), and 53% had experienced a reactivation of
cytomegalovirus (CMV). Lere were no group diKerences in
demographic, medical, and baseline psychosocial character-
istics (Table 1). POMS-SF ratings before and a[er session 4
were obtained for 97% of participants (MT = 28 and UM =
29) and mood ratings before and a[er listening to CDs
during follow-up were obtained from 85% of participants
(MT = 24 and UM = 26). Lere were no signiTcant group
diKerences in loss to follow-up. Le mean number of days
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Women N (%) 14 (48) 12 (40) 21 (68)
Mean age (SD) 43.72 (14.63) 44.07 (13.56) 45.19 (11.04)
Ethnicity N (%)
White 20 (69) 20 (67) 19 (61)
African American 0 (0) 3 (10) 4 (13)
Hispanic/Latino 4 (14) 4 (13) 3 (10)
Asian 1 (3) 1 (3) 2 (6)
Other 4 (14) 2 (7) 3 (10)
Marriage status N (%)
Married 20 (69) 22 (73) 18 (58)
Divorced 2 (7) 1 (3) 2 (6)
Never married 5 (17) 2 (7) 6 (19)
Declined to answer 2 (7) 5 (17) 5 (16)
Education N (%)
High school diploma 3 (10) 6 (20) 2 (6)
Some college 12 (41) 11 (37) 12 (39)
College degree 7 (24) 7 (23) 10 (32)
Graduate degree 4 (14) 4 (13) 3 (10)
Declined to answer 2 (7) 2 (7) 4 (13)
Diagnosis N (%)
Leukemia 18 (62) 20 (67) 19 (70)
Lymphoma 6 (21) 2 (7) 5 (19)
Other 5 (17) 8 (27) 7 (11)
Donor match status
Matched related 18 (62) 16 (53) 17 (55)
Matched unrelated 8 (28) 11 (37) 9 (29)
Unmatched unrelated 1 (3) 1 (3) 1 (3)
Unknown 2 (7) 2 (7) 4 (13)
Donor cell type N (%)
Peripheral blood 18 (62) 17 (57) 18 (58)
Bone marrow 9 (31) 11 (37) 8 (26)
Umbilical cord/placenta 0 (0) 0 (0) 1 (3)
Unknown 2 (7) 2 (7) 2 (6)
Baseline GVHD N (%)
None 19 (66) 15 (50) 20 (65)
Grade 1 5 (17) 6 (20) 5 (16)
Grade 2 4 (14) 6 (20) 4 (13)
Grade 3 or 4 1 (3) 3 (10) 2 (6)
Baseline CMVR N (%) yes 13 (45) 17 (57) 18 (58)
Mean days since transplant (SD) 25.52 (10.10) 26.96 (9.40) 30.04 (12.10)
GVHD: graph-versus-host disease; CMVR: cytomegalovirus reactivation.
since transplant was higher for those who dropped out of the
study by the 1-month follow-up compared to those who did
not drop out of the study (34.5, SD = 15.20 versus 25.24, SD
= 7.52). Otherwise, the demographic, medical, and baseline
psychosocial variables did not diKer between patients who
did and did not drop out of the study by the 1-month follow-
up.
3.2. Adherence and Feasibility. Lere were no diKerences
between MT and UM groups in their reported use of the
Evidence-Based Complementary and Alternative Medicine 5
CDs at 1-month follow-up. Patient reports of the frequency
or duration of CD use were not related to study outcomes.
Additionally, therewas no diKerence in frequency or duration
of CD use between the two types of CDs (relaxing versus
energizing) within the MT and UM groups. Participants
listened to music CDs with an average of 9.90 (SD = 6.86)
times for 38.87 (SD = 43.58) minutes each time during the 1-
month follow-up.Lere were no diKerences betweenMT and
UM groups in any report of satisfaction.
3.3. Demographic and Medical Variables Associated with
Psychosocial Outcomes. Donor-recipient match status, CMV
reactivation status, gra[-versus-host disease (GVHD) status,
time since transplant, and sex were not associated with
any short- or long-term psychosocial outcomes. Diagnosis
was associated with FACT-G (" < 0.01) and BMT (" =
0.02) scores at 1-week follow-up and BMT (" = 0.01) and
POMS-SF (" = 0.01) scores at 1-month follow-up. Lym-
phoma patients reported higher general QOL compared to
patients with leukemia or other diagnoses (i.e., renal, breast,
or ovarian cancer and aplastic anemia) at 1-week follow-
up ("’s < 0.01); however, patients diagnosed with either
lymphoma or leukemia tended to report higher BMT-speciTc
QOL compared to patients with other diagnoses (QOL at
1-week and 1-month follow-up; "’s < 0.05). Additionally,
patients diagnosed with leukemia tended to report lower
mood disturbance and fewer symptoms compared to patients
with lymphoma or other diagnoses at 1-month follow-up
("’s < 0.01). Gra[ type (peripheral blood, bone marrow,
or umbilical cord/placenta) was associated with MDASI at
1-week follow-up (" = 0.05) and FACT-G at 1-month
(" = 0.04) follow-up. SpeciTcally, individuals who received
cells derived from umbilical cord/placenta reported poorer
QOL and greater symptoms than those with cells derived
from marrow or peripheral blood ("’s < 0.05). Furthermore,
ethnicity was associated with POMS-SF, FACT-G, BMT, and
MDASI scores at 1-week follow-up ("’s< 0.03). Non-Hispanic
white participants reported better general and BMT-related
QOL compared to Hispanic participants and lower MDASI
scores compared to African American participants ("’s <
0.05). Hispanic participants reported higher POMS-SF scores
compared to non-Hispanic white and African American
participants ("’s < 0.01). Lastly, age was associated with
POMS-SF and MDASI scores at 1-month follow-up, with
older participants reporting greater mood disturbance and
symptoms ("’s < 0.05). Lus, diagnosis, donor cell type,
ethnicity, and age were entered as covariates in analyses
examining group diKerences in self-reported short- and long-
term outcome measures.
3.4. Short-Term EZects. Le Trst short-term outcome
(POMS-SF total score before and a[er the Tnal music
session) was examined using LMM covarying for baseline
POMS score, diagnosis, donor cell type, ethnicity, and age.
Results revealed a signiTcant eKect of time (i.e., before versus
a[er session 4; " < 0.0001), with individuals reporting
reduced mood disturbance a[er their Tnal music session



























Figure 1: Least squaredmeans ofmood ratings before and a[er Tnal
music session. All means are adjusted for diagnosis, donor cell type,
ethnicity, age, and baseline POMS-SF total score. POMS-SF scores
were signiTcantly reduced from before to a[er Tnal music session
(session 4) regardless of group. ∗∗∗" < 0.0001. MT: music therapy;
UM: unstructured music.
for least squared means). Lere was no eKect of group or
group-by-time interaction on POMS-SF scores a[er the Tnal
music session.
Le second short-term outcome (mood before and a[er
listening to CDs at the 1-month follow-up) was examined
using LMM, covarying for diagnosis, donor cell type, ethnic-
ity, age, and the number of minutes that patients listened to
their CDs. Results did not reveal a signiTcant eKect of group
on relaxation/tension or happiness/sadness ratings. Analyses
did indicate a signiTcant eKect for time (i.e., before versus
a[er listening) for both CDs (relaxing and energizing) on
ratings of relaxation/tension and happiness/sadness (all "’s
< 0.0001; see Figures 2(a)–2(d) for least squared means),
such that mood was rated as more relaxed and happier a[er
listening to the CDs. Lough there was no group-by-time
interaction eKect for the relaxing CD on relaxation/tension
ratings (Figure 2(a)), signiTcant group-by-time interaction
eKects were found for the relaxing CD on happiness/sadness
ratings (" < 0.01; Figure 2(b)) and for the energizing
CD on relaxation/tension (" < 0.001; Figure 2(c)) and
happiness/sadness (" < 0.01; Figure 2(d)) ratings. However,
post hoc analysis comparing the MT and UM groups at
each time point (i.e., before and a[er listening to music) did
not reveal any signiTcant group diKerences in mood ratings
before or a[er listening to either CD (all "’s > 0.07).
3.5. Long-Term EZects. LMM analyses, controlling for the
baseline score of the outcome variables and covarying for
diagnosis, donor cell type, ethnicity, and age, did not reveal a
signiTcant eKect of group, time, or group-by-time interaction
on FACT-G, BMT, POMS-SF, or MDASI scores (Table 2).
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Energizing CD
(d)
Figure 2: Least squared means of mood ratings before and a[er listening to CDs outside of session. All means are adjusted for diagnosis,
donor cell type, ethnicity, age, and number of minutes the individual listened to the respective CD. All means improved from before to a[er
listening (" < 0.0001). A signiTcant group-by-time interaction eKect was found in Figures (b)–(d) (" < 0.01), though post hoc #-test did
not reveal signiTcant group diKerences before or a[er listening (" > 0.07). Mood assessed by rating relaxation/tension on a 1 (extremely
relaxed) to 10 (extremely tense) scale and happiness/sadness on a 1 (extremely happy) to 10 (extremely sad) scale. MT: music therapy; UM:
unstructured music.
Exploratory LLM analyses were then conducted to examine
the eKect of time (frombaseline to 1month a[er intervention)
on psychosocial outcome measures for all groups. Group,
diagnosis, donor cell type, ethnicity, and age were entered as
covariates. Patients reported improved FACT-G (" = 0.001),
BMT (" = 0.001), POMS-SF (" < 0.0001), and MDASI
(" = 0.01) scores over time (from baseline to 1 month a[er
intervention).
4. Discussion
LeTndings of the present study did not support our hypoth-
esis that listening to CDs that follow the ISO principle would
result in greater acute improvement in mood compared to
listening to unstructured CDs designed by participants to
relax or energize. Indeed, participants (regardless of group)
reported improved mood immediately a[er listening to their
Evidence-Based Complementary and Alternative Medicine 7
Table 2: Mean Functional Assessment of Cancer Lerapy-General
(FACT-G), Bone Marrow Transplant subscale (BMT), ProTle of












MT 76.70 (14.79) 77.92 (12.00) 82.81 (15.77)
PM 70.05 (17.88) 74.84 (13.70) 75.76 (13.22)
UC 71.98 (15.97) 73.12 (13.97) 75.85 (16.00)
BMT
MT 26.29 (5.56) 27.57 (5.45) 28.41 (6.28)
PM 23.20 (6.47) 24.99 (5.48) 25.51 (4.30)
UC 22.82 (6.14) 24.00 (5.80) 24.92 (5.96)
POMS-SF
MT 15.31 (19.975) 8.59 (19.12) 5.70 (24.92)
PM 14.30 (16.397) 5.11 (14.53) 6.38 (20.02)
UC 16.06 (23.123) 9.32 (20.21) 8.29 (15.29)
MDASI
MT 2.31 (1.71) 2.08 (1.62) 1.92 (2.19)
PM 3.05 (1.73) 2.47 (1.14) 2.15 (1.20)
UC 2.69 (1.74) 2.73 (1.90) 2.31 (1.41)
SD: standard deviation; MT: music therapy; PM: unstructured music; UC:
usual care.
playlists, both during session 4 and the 1-month follow-up.
Interestingly, participants listening to unstructured playlists
reported slightly greater improvements inmood immediately
a[er listening to their CDs during the 1-month follow-
up compared to participants whose playlists followed the
ISO principle, with tracks gradually transitioning in tempo
and mood from anxious to relaxed or from depressed to
energized.
Lere are several possible reasons for why the ISO-based
music therapy intervention did not result in greater improve-
ments in acute mood compared to unstructured music
listening. First, there is little research on the ideal parameters
to use when implementing ISO principle (e.g., length of time
between musical track transitions, etc.), making it possible
that a diKerent implementation of the ISO principlemay have
been more eKective at improving mood than the method
used in the present study. Additionally, there are no studies
examining the ISO principle in a medical population, and in
fact the theory was developed to assist psychiatric inpatients
in managing their mood. Lus, it is possible that patients
without clinical mood disorders derive greater beneTt from
listening to consistently relaxing or energizing music, rather
than listening to playlists transitioning from one music type
to another. In addition, patients in the MT were constrained
to listening to music therapy tracks in an order that followed
the ISO principle, whereas the UM group had the freedom
to choose their songs in any order. Le imposition of a
structured order of music may have taken away personal
preference and may have accounted for the improvement in
the UM group.
Le present study did not support our secondary hypoth-
esis that individuals in ISO principle music therapy inter-
vention would derive greater long-term beneTt than patients
in an unstructured music listening or a usual care control
group or that those in an unstructured music listening group
would report better QOL than those receiving usual care.
Moreover, independent of group assignment, individuals
reported signiTcant improvements in QOL from baseline
to 1 month a[er intervention, echoing previous research
suggesting that QOL continues to improve during the Trst
100 days a[er transplant [1, 2]. Lere are several possible
reasons for the lack of beneTt. First, participants reported
that they listened to the CDs infrequently (only nine times on
average during the one-month period a[er the intervention).
It is possible that, with more frequent use, a long-term eKect
of music listening on QOL may have been found. Lis may
be especially important for the MT group, as the length
of exposure to a particular beat may determine the brain’s
ability to entrain, or to assume the rhythm of the musical
selection, which then permits the progressive transition from
one state to another described in the ISO principle [28].
Short presentations of as little as four minutes (the maximum
length of most music tracks) of binaural beats may not be
subcient to alter patient’s physiological vigilance, thereby
making it impossible to fully “transition” fromonemood state
to another [29]. Second, the time at which the intervention
was conducted may be another reason for the lack of long-
term intervention eKect. Patients were recruited at an average
of 28 days a[er transplant, a[er much of their recovery had
already taken place [30]. It is possible that delivery of our
intervention at an earlier time point could have signiTcantly
aKected patient outcome. Relatedly, it is important to note the
potential for a “ceiling eKect” for the psychosocial outcomes.
Lis ceiling eKect may have le[ little room for improvement,
meaning that it is possible that patients who volunteered to
participate in this study may have been doing relatively well
physically and emotionally compared to theirmore impaired,
possibly hospitalized, transplant patient peers. In fact, the
FACT-G means reported at baseline in the present study
(% = 73.78; SD = 14.40) were within 1 standard deviation
of the established norms for the general United States adult
population (% = 80.1; SD = 18.1) [31]. However, Sherman
and colleagues report a mean FACT-G score for a post-
HSCT sample that is comparable to ours (% = 71.31; SD =
15.37), suggesting that our sample may have been an accurate
representation of post-BMT patients [32].
Loughmusic therapy was not related to study outcomes,
several medical and demographic variables were associated
with QOL, mood, and cancer-related symptoms. First, the
present study indicates that older patients experience greater
mood disturbance following HSCT. Similarly, Niederbacher
et al. [33] also found that age was associated with mood
disturbance, although their study suggests that middle age
patients may experience the greatest distress compared to the
oldest and youngest patient groups in some measures. Sec-
ondly, unlike previous research that reported no association
between ethnicity andQOL [34], we found that non-Hispanic
white patients tend to report less severe symptoms and
better QOL following HSCT compared to patients of ethnic
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minorities and that African American patients may expe-
rience less mood disturbances following HSCT compared
to Hispanic participants. Similar to Tndings from previous
studies [35], the present study suggests that diagnosis may
be related to QOL following HSCT, with patients diagnosed
with lymphoma experiencing better posttransplant QOL
compared to patients with other diagnoses. Lastly, present
Tndings suggest that individuals receiving transplant cells
derived from umbilical cord/placenta may experience poorer
QOL and greater symptoms than those whose gra[s are
derived from bone marrow or peripheral blood. Lough this
association has not been previously reported, many studies
have excluded patients receiving cells derived from umbilical
cord/placenta, likely due to their relatively small numbers
[36, 37].
Lere are several limitations in this study. Lough there
was no gender eKect, it is important to note that the therapist
working with the MT group was male and the therapist
working with the UM group was female. Using one therapist
to treat both intervention and active control group introduces
a potential unintentional bias in how they work with the
groups. Additionally, there was relatively high attrition (25%)
at 1 month, and thus the results may not be generalizable.
Lastly, themajority of participants were white, non-Hispanic,
married, and highly educated.Lus, future research is needed
to test the generalizability of these Tndings to more diverse
populations.
Although the present study did not reveal long-term
QOL group diKerences in response to two music therapy
interventions, it did show that listening to music identiTed
as “relaxing” and “energizing” results in acute improvements
in mood. Furthermore, the present study suggests that this
eKect may be slightly greater when individuals listen to
unstructured playlists consisting of music they identify as
“relaxing” or “energizing” compared to playlists designed
to gradually transition to “relaxing” or energizing.” Lose
wishing to further investigate the eKects of the ISO princi-
ple music therapy technique should consider ensuring that
the music choice options are all patient-derived and then
assembled by the therapist based on BPM.Lis will allow the
greatest connection for the patients. Future studies examining
music therapy in this population should focus on methods
to increase patient compliance to music listening to optimize
long-term beneTts.
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